GenSpera Announces Encouraging Interim Phase II Data for Glioblastoma, Showcases Positive Future for Mipsagargin Across Multiple Types of Solid Tumors
September 09, 2015 08:00 ET
|
GenSpera, Inc.
SAN ANTONIO, TX--(Marketwired - Sep 9, 2015) - GenSpera, Inc. (OTCQB: GNSZ) today announced that interim data from its Phase II study of mipsagargin (G-202) in adult patients with recurrent or...
PCG Advisory Group (PCG) Announces 19 Clients to Present at Rodman and Renshaw 17th Annual Global Investment Conference
September 02, 2015 16:59 ET
|
PCG Advisory
NEW YORK, NY--(Marketwired - Sep 2, 2015) - PCG Advisory Group (PCG), a leading investor and public relations firm specializing in digital and social media strategies, announced today that a record...
GenSpera to Present at Rodman & Renshaw 17th Annual Global Investment Conference
August 24, 2015 08:30 ET
|
GenSpera Inc.
SAN ANTONIO, TX--(Marketwired - Aug 24, 2015) - GenSpera, Inc. (OTCQB: GNSZ) announced today that Craig A. Dionne, Ph.D., chairman and chief executive officer at GenSpera, will present at Rodman...
GenSpera Provides 2nd Quarter Corporate Update
August 10, 2015 08:30 ET
|
GenSpera
SAN ANTONIO, TX--(Marketwired - Aug 10, 2015) - GenSpera, Inc. (OTCQB: GNSZ) on August 6, 2015, the company reported its financial results for the three and six months ended June 31, 2015, and has...
GenSpera Phase II Abstract Accepted for Presentation at the Society of Neuro-Oncology 20th Annual Scientific Meeting
July 28, 2015 08:30 ET
|
GenSpera
SAN ANTONIO, TX--(Marketwired - Jul 28, 2015) - GenSpera, Inc. (OTCQB: GNSZ) announced today that the Society for Neuro-Oncology and the 2015 Scientific Program Committee has accepted an abstract...
U.S. Court of Appeals Enters Judgment in Favor of GenSpera
July 20, 2015 08:00 ET
|
GenSpera
SAN ANTONIO, TX--(Marketwired - Jul 20, 2015) - GenSpera, Inc. (OTCQB: GNSZ) announced today the U.S. Court of Appeals for the Federal Circuit found in favor of GenSpera.
On July 16, 2015,...
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)
July 13, 2015 08:30 ET
|
GenSpera
SAN ANTONIO, TX--(Marketwired - Jul 13, 2015) - GenSpera, Inc. (OTCQB: GNSZ) today announced that its strategic partner Phyton Biotech, the pioneer in Plant Cell Fermentation (PCF®), has had...
GenSpera Announces Private Placement of $2.5 Million
July 06, 2015 09:00 ET
|
GenSpera
SAN ANTONIO, TX--(Marketwired - Jul 6, 2015) - GenSpera, Inc. (OTCQB: GNSZ) announced today that it has entered into definitive agreements with institutional investors, led by a healthcare...
U.S. Food and Drug Administration's Office of Orphan Products Development Issues Grant Supporting GenSperas Glioblastoma Study
June 17, 2015 08:30 ET
|
GenSpera, Inc.
SAN ANTONIO, TX--(Marketwired - Jun 17, 2015) - GenSpera, Inc. (OTCQB: GNSZ) announced today that Santosh Kesari, MD, PhD, Principal Investigator of GenSpera's glioblastoma clinical trial, received...
Craig A. Dionne to Speak at BIO International 2015
June 15, 2015 08:30 ET
|
GenSpera
SAN ANTONIO, TX and PHILADELPHIA, PA--(Marketwired - Jun 15, 2015) - GenSpera, Inc. (OTCQB: GNSZ) announced today that Craig A. Dionne, Ph.D., chairman and chief executive officer at GenSpera, will...